The Trans-Pacific Partnership (TPP) is bad medicine. This trade deal, which was recently signed by Canada, the United States, Mexico and nine other Pacific Rim countries, will keep the costs of prescription medications high, undermine the ability to draft quality public health care policy, and make it more difficult to create a national pharmacare program.
The TPP is a corporate power grab, and one of the biggest benefactors of the deal is the pharmaceutical industry (”Big Pharma”).
Read more about how the TPP will benefit Big Pharma at the expense of Canadians.
